On behalf of the operating committee, we are pleased to announce that the Global Congress on Rare Diseases and Orphan Drugs will be held during November 28, 2020. Rare Diseases Congress 2020 provides a head interdisciplinary stage for analysts to introduce the most recent research discoveries and portray developing advances, and bearings in uncommon illnesses and vagrant medications issues. The event attempts to contribute to presenting novel research results in all aspects of Rare Diseases and Orphan Drugs.
Rare Diseases Congress 2020 provides a platform for scientists, professors, specialists, researchers, students, and practitioners to present their latest research results, ideas, developments, and applications in all areas of rare diseases and orphan drugs. The meeting will unite driving scholastic researchers, scientists, Industrialagents Healthcare Professionals, and researchers in the space of enthusiasm from around the globe.
Many rare diseases/orphan diseases caused by infectious agents rather than genetic or environmental factors.
A rare disease is defined as a condition that affects less than 200,000 people. Most of the rare diseases are genetic
Diagnostic error in medicine is prevalent. For example, a study from an intensive care unit demonstrated nearly 20%
There are approximately 7,000 rare diseases, which from a regulatory outlook are defined as those diseases where there
Millions of people live with at least one skin condition. Skin diseases affect one in four Americans
The advancement of Pharma Industries has eased back as of late due to numerous reasons such as patent generic
A clinical preliminary is a therapeutic report led to test the impacts of another or effectively existing medication
A genetic disorder is a health problem caused by one or more abnormalities in the genome. It can be caused by a mutation
